[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine

C9H15F3N2O2 — CID 103217748

IUPAC[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine
SMILESNNC(COCC(F)(F)F)C1=COCCC1
InChIInChI=1S/C9H15F3N2O2/c10-9(11,12)6-16-5-8(14-13)7-2-1-3-15-4-7/h4,8,14H,1-3,5-6,13H2
InChIKeyBEHMQDUHAJCUGS-UHFFFAOYSA-N
MW240.22 g/mol
LogP1.09
Rot. Bonds5

About [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine

[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine (PubChem CID 103217748) has the molecular formula C9H15F3N2O2 and a molecular weight of 240.22 g/mol. Its IUPAC name is [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine.

Molecular Properties

Compound Name[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine
PubChem CID103217748
Molecular FormulaC9H15F3N2O2
Molecular Weight240.22 g/mol
Exact Mass240.11
IUPAC Name[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine
SMILESNNC(COCC(F)(F)F)C1=COCCC1
InChIInChI=1S/C9H15F3N2O2/c10-9(11,12)6-16-5-8(14-13)7-2-1-3-15-4-7/h4,8,14H,1-3,5-6,13H2
InChIKeyBEHMQDUHAJCUGS-UHFFFAOYSA-N
XLogP1.09
TPSA56.51 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms16
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500240.22
LogP ≤ 51.09
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[1-(3,4-dihydro-2H-pyran-5-yl)-3-(2,2,2-trifluoroethoxy)propyl]hydrazine
CID 103151719
[3-(2,2-difluoroethoxy)-1-(3,4-dihydro-2H-pyran-5-yl)propyl]hydrazine
CID 103152058
1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethanamine
CID 103216169
1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,3,3-tetrafluoropropoxy)ethanamine
CID 103475118
[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,3,3-tetrafluoropropoxy)ethyl]hydrazine
CID 103477849
[1-(3,4-dihydro-2H-pyran-5-yl)-3,3,3-trifluoropropyl]hydrazine
CID 105205875
[1-(3,4-dihydro-2H-pyran-5-yl)-2,2,2-trifluoroethyl]hydrazine
CID 105215579
[1-(3,4-dihydro-2H-pyran-5-yl)-4,4,4-trifluorobutyl]hydrazine
CID 105248892
[1-(3,4-dihydro-2H-pyran-5-yl)-2,2-difluoroethyl]hydrazine
CID 105264984
[1-(Oxolan-2-yl)-2-(trifluoromethyl)prop-2-en-1-yl]hydrazine
CID 165344018
[1-(3,4-dihydro-2H-pyran-5-yl)-2-methoxyethyl]hydrazine
CID 105207114
[1-(3,4-dihydro-2H-pyran-5-yl)-2-propoxyethyl]hydrazine
CID 105209902

Frequently Asked Questions

What is the IUPAC name of [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine?
The IUPAC name of [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine (CID 103217748) is [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine.
What is the SMILES notation for [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine?
The canonical SMILES for [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine is NNC(COCC(F)(F)F)C1=COCCC1.
What is the InChIKey of [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine?
The InChIKey is BEHMQDUHAJCUGS-UHFFFAOYSA-N. The full InChI is InChI=1S/C9H15F3N2O2/c10-9(11,12)6-16-5-8(14-13)7-2-1-3-15-4-7/h4,8,14H,1-3,5-6,13H2.
What are the key properties of [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine?
[1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine has a molecular weight of 240.22 g/mol, XLogP of 1.09, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(3,4-dihydro-2H-pyran-5-yl)-2-(2,2,2-trifluoroethoxy)ethyl]hydrazine is sourced from PubChem (CID 103217748), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).